drugset / Trial / NCT00832520
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to find out if remeron, also called mirtazapine, can help you prevent weight loss while on treatment for your cancer. Remeron is currently used to treat depression and has not been approved by the Food and Drug Administration for use to treat weight loss.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-07
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 7.5 mg | Oral |
| Subject | Mirtazapine | Other / unclassified | 15 mg | Oral |